Free Anti-Rituximab
Detecting the development of Anti-drug antibodies (ADAs) against Rituximab in patients being treated with Rituximab
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Rituximab can detect the presence of anti-drug antibodies against Rituximab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
About Using Reagent
-
Sample Types
Serum, Whole blood -
Reaction Time
12 mins -
Detection Range
5-200 ng/mL -
Intended Use
Quantitative determination of free antibodies against Rituximab including in human whole blood/serum.
In Your Medical Field
AFIAS Free Anti-Rituximab detects anti-drug antibodies against Rituximab in just 12 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Rituximab.